Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fina Biosolutions does not run its own clinical trials but provides enabling technology and products used in marketed vaccines worldwide. Its proprietary conjugation chemistry has been licensed by major vaccine manufacturers such as GSK and the Serum Institute of India for use in approved products like Synflorix, Menitorix, Nimenrix. The company’s recombinant CRM197 carrier protein supports both preclinical research and GMP-grade clinical/commercial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fina Biosolutions LLC.